Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski +6 more
wiley +1 more source
Application of an innovative biventricular assist device for bridge-to-transplant in a low-weight child with end-stage restrictive cardiomyopathy. [PDF]
Liu X +18 more
europepmc +1 more source
This study aimed to assess diagnostic delay among patients with eosinophilic granulomatosis with polyangiitis (EGPA) and identify clinical characteristics associated with delayed recognition. EGPA diagnosis was delayed by nearly five years from symptom onset in this single‐center cohort.
Vani Mulkareddy +9 more
wiley +1 more source
From sudden stroke to heart transplant: unmasking restrictive cardiomyopathy in an adolescent: a case report. [PDF]
López-Guillén JL +4 more
europepmc +1 more source
Pediatric restrictive cardiomyopathy: a case report. [PDF]
Dai HL +4 more
europepmc +1 more source
The fetal phenotype is a trajectory, not a snapshot
The evolving fetal phenotype. Serial prenatal ultrasound may reveal emerging or changing fetal features that inform reassessment of genetic findings. Reporting the timing of observations, changes in the fetal phenotype and any subsequent revision of variant interpretation helps clarify the contribution of longitudinal imaging to prenatal diagnosis ...
Florian Recker +2 more
wiley +1 more source
Restrictive cardiomyopathy due to new mutation in the ACTN2 gene: a case report. [PDF]
Lan B, Liu Z, Bai J, Tang J, Zhang J.
europepmc +1 more source
Initial V‐A ECMO Flow‐Index and Its Association With Inflammation, Organ Failure, and Outcomes
Higher initial V‐A ECMO flow‐index was associated with greater shock severity and independently associated with multi‐organ failure. Early hemolysis may partly contribute to this association, particularly in eCPR patients, whereas no significant indirect effect through IL‐6 was observed.
Kostiantyn Kozakov +9 more
wiley +1 more source
The evolving landscape of restrictive cardiomyopathy treatment: clinical trial trends and future directions. [PDF]
Deng B, Liu W.
europepmc +1 more source
HeartWare‐BiVAD was associated with more frequent right ventricular cannulation, whereas HM3‐BiVAD demonstrated a trend toward improved survival despite a more severe preimplant clinical profile, suggesting a potential device‐related advantage of HM3 in biventricular support.
Daler Rahimov +10 more
wiley +1 more source

